PL
PL · PL · PL-100096712
ReFacto AF
ATC B02BD02
Last synced from URPL (Poland) on
Identification
ManufacturerPfizer Europe MA EEIG
CountryPL (PL)
ATC codeB02BD02
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 2
- gtin05909990819416
- gtin05909990880805
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań",
"source": "urpl",
"strength": "500 j.m. (125 j.m./ml)",
"packaging": "05909990819416 ¦ Rpz ¦ EU/1/99/103/002 ¦ 16159\n1 fiol. proszku + 1 amp.-strzyk. rozp.\n05909990880805 ¦ Rpz ¦ EU/1/99/103/006 ¦ 105200\n1 amp.-strzyk. 500 j.m. + 4 ml. rozp.",
"substance": "Moroctocogum alfa 500 j.m.",
"common_name": "Moroctocogum alfa. Czynnik VIII krzepnięcia krwi ludzki rekombinowany",
"pl_product_id": "100096712",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code B02BD02.
- ISAdvateTakeda Manufacturing Austria AG
- ISAdvateTakeda Manufacturing Austria AG
- ISAdvateTakeda Manufacturing Austria AG
- ISAdvateTakeda Manufacturing Austria AG
- ISAdvateTakeda Manufacturing Austria AG
- ISAdvateTakeda Manufacturing Austria AG
- ISAdvateTakeda Manufacturing Austria AG
- ISAdvateTakeda Manufacturing Austria AG
Access this data programmatically
Query ReFacto AF and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.